Efficacy and tolerance of ivermectin in human onchocerciasis (1982)

Peer-Reviewed Study · Aziz MA, Diallo S, Diop IM, Lariviere M, Porta M · 1982

Aziz MA et al., 1982: The first controlled clinical study of ivermectin in human onchocerciasis, in 32 Senegalese subjects, showing dose-dependent clearance of skin microfilariae at 30-50 micrograms/kg given as a single oral dose.

they were greatly reduced in all subjects after single oral doses of 30 micrograms or 50 micrograms/kg and were eliminated completely in 6 of th 8 subjects who received the 50 micrograms/kg dose

Aziz MA et al., 1982: The first controlled clinical study of ivermectin in human onchocerciasis, in 32 Senegalese subjects, showing dose-dependent clearance of skin microfilariae at 30-50 micrograms/kg given as a single oral dose. Randomized controlled clinical trial (PubMed types: Clinical Trial, Randomized Controlled Trial), N=32, Senegal. Single oral doses of 5, 10, 30 or 50 micrograms/kg; no microfilarial reduction at 5-10, major reduction at 30, complete clearance in 6 of 8 at 50. Comparator: dose groups (no placebo arm described in the abstract). Funder not stated in the abstract; Merck supplied the drug in this era (not stated in this record). No disclosure statement in the 1982 record. Quote is copied from the PubMed abstract text exactly as indexed, including the record's own 'th 8' typo; source_url is the PubMed record because the Lancet full text is paywalled.